• Annexin V-HF647/PI Apoptosis Kit in ESCC

  2026-09-17

  The Annexin V-HF647/PI Apoptosis Kit provides a practical way to quantify apoptosis-associated membrane changes in ESCC models. This guide connects flow-cytometric assay design with the HOXC9–AKT/mTOR findings and explains why Annexin V/PI data should be interpreted alongside mitochondrial and molecular readouts.

• Annexin V-Cy5 Apoptosis Kit Workflow

  2026-09-17

  Use the Annexin V-Cy5 Apoptosis Kit to distinguish phosphatidylserine exposure from lysosomal stress in microglia and other experimental systems. Its 10-minute staining workflow supports both rapid flow cytometry apoptosis detection and spatial fluorescence microscopy apoptosis analysis.

• CAPE NF-κB Assay Workflow and Applications

  2026-09-16

  Caffeic Acid Phenethyl Ester (CAPE) provides a practical chemical perturbation tool for dissecting NF-κB-dependent inflammation, angiogenesis, and tumor invasion. This workflow connects CAPE dose-response testing with the Stat3–NF-κB biology of Fyn-driven neurodegeneration while clearly separating established evidence from proposed assay extensions.

• Annexin V-Cy5 Apoptosis Kit for Microglia

  2026-09-16

  Use the Annexin V-Cy5 Apoptosis Kit to separate genuine phosphatidylserine-positive cell death from lysosomal stress in demanding microglial models. Its rapid staining workflow supports both flow cytometry apoptosis detection and fluorescence microscopy apoptosis analysis, making it useful for time-course and mechanism-focused experiments.

• DiscoveryProbe L1042: From Hits to Immune Mechanisms

  2026-09-15

  DiscoveryProbe Immunology/Inflammation Compound Library L1042 connects multiparametric PBMC phenotyping with mechanism-oriented immunomodulator screening. This guide explains how to distinguish pathway activity from cytotoxicity, prioritize targets, and translate immune phenotypes into actionable follow-up experiments.

• Belinostat (PXD101) and the Acetylation–Splicing Axis

  2026-09-15

  Belinostat (PXD101) offers a practical entry point for studying how pan-HDAC activity connects chromatin acetylation, cell-cycle control, spliceosome regulation, and DNA-damage response. This thought-leadership article translates mechanistic findings from hepatocellular carcinoma research into a disciplined framework for bladder, prostate, and broader tumor-model studies.

• INO80 Enables Postreplicative DNA Gap Repair

  2026-09-14

  The reference study identifies the INO80 chromatin remodeller as a downstream facilitator of PCNA-dependent DNA damage bypass, supporting both daughter-strand gap expansion and subsequent gap filling. Its findings separate this activity from H2A.Z exchange, transcriptional regulation, and double-strand break repair, and support a model in which INO80 positions nucleosomes to provide access for repair enzymes.

• FLOT1–FOSL2–EphA2 Axis in AD Neuroinflammation

  2026-09-14

  The reference study identifies a FLOT1–FOSL2–EphA2 signaling axis that promotes pro-inflammatory microglial polarization through p38/MAPK signaling in Alzheimer’s disease models. Its combination of molecular interaction assays, transcriptional analysis, and APP/PS1 mouse experiments links this pathway to neuroinflammation and impaired spatial memory, while also defining important limits for translation to Aβ25-35-based systems.

• HotStart 2X Green qPCR Master Mix for DNMT3B

  2026-09-13

  Use a hot-start SYBR Green workflow to translate DNMT3B findings into reproducible cervical cancer expression assays. This guide combines assay setup, RNA-seq validation, controls, and troubleshooting for sensitive nucleic acid quantification without overstating what qPCR can prove.

• Lactylation–NSUN2 Drives PDAC Perineural Invasion

  2026-09-12

  A 2026 study identifies NSUN2 K692 lactylation as a metabolic switch that links lactate accumulation to RNA m5C-dependent stabilization of CDCP1 and STC1 in pancreatic ductal adenocarcinoma. By combining patient samples, mechanistic cell assays, nerve co-culture, and mouse models, the work explains how metabolic stress promotes perineural invasion and suggests intervention points for limiting neural tumor spread.

• Catalpol: From Pathway Pleiotropy to Assay Design

  2026-09-11

  Catalpol, also known as Catalpinoside, is a multi-target iridoid glycoside with applications spanning neuroprotection research and inflammatory disease models. This article converts its pathway biology into a practical, causally disciplined framework for selecting assays, controls, and preclinical endpoints.

• AI-10-49 Workflow for CBFβ-SMMHC AML Research

  2026-09-11

  AI-10-49 enables a mechanism-led workflow that connects CBFβ-SMMHC–RUNX1 dissociation with chromatin, transcriptional, survival, and animal-model readouts. Its strongest use case is inv(16) leukemia research, where target engagement can be paired with MYCN/eIF4G1 pathway analysis and carefully controlled phenotypic assays.

• FAISL–FAK Proteolysis in Triple-Negative Breast Cancer

  2026-09-10

  The reference study identifies FAISL as a long noncoding RNA that stabilizes focal adhesion kinase by blocking Calpain-2-mediated proteolysis, thereby promoting triple-negative breast cancer progression and metastasis. Its combination of transcriptomic discovery, molecular interaction analysis, functional assays, and nanoparticle-mediated siRNA delivery establishes a mechanistic basis for targeting FAISL rather than FAK kinase activity alone.

• QPRT, PLC Signaling, and Breast Cancer Invasion

  2026-09-10

  Liu et al. showed that elevated quinolinate phosphoribosyltransferase (QPRT) is associated with invasive breast cancer and promotes migration and invasion through myosin light chain phosphorylation. Genetic perturbation and inhibitor-based experiments connected QPRT activity with purinergic, Rho–ROCK, PLC, and MLCK signaling, providing a mechanistic framework for studying breast cancer cell motility.

• Geneticin Beyond Selection: A Translational Strategy

  2026-09-09

  Geneticin, also known as G418 Sulfate, is more than a routine selection reagent. Its ribosomal mechanism, selective pressure profile, and reported antiviral activity create a translational framework for better cell-line development, assay design, and Dengue virus research. This article connects G418 workflows with transporter-aware experimental thinking while defining the boundaries between established evidence and forward-looking application.

8040 records 1/536 page Next 12345 下5页 Last page